Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Teneo.ai Partners with AppDirect to Revolutionize Voice AI Solutions in the U.S., Delivering Up to 50% Cost Savings in AI-Driven Phone Support

Teneo.ai , a leader in Voice AI technology, is pleased to announce its strategic partnership with AppDirect , a premier B2B subscription commerce platform. This collaboration aims to make Teneo’s advanced AI-driven conversational solutions widely accessible to U.S. businesses through the AppDirect marketplace, addressing the growing demand for voice-enabled customer service automation and AI-powered phone support.Based in San Francisco, AppDirect has long been a driving force in B2B subscription commerce, celebrated for its extensive network

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 273 – 16 DECEMBER 2024    In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 235/24 and 237/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Therese Möllevinge, Head of Investor Relations, tel.: +45 41 37 16 38, e-mail: thm@norden.com Isabella Zaugg Hansen, Investor Relations Manager, tel.: +45 27 62 90 96, e-mail: izh@norden.com

Boho Group Advances Key Development Plans in Marbella

Boho Group AB (publ) is proud to announce a significant milestone in our ongoing collaboration with Marbella Municipality. After many months of intensive work and close collaboration, Boho Group has officially submitted the required materials and documentation to Marbella municipality for the zoning application in order to seek a preliminary approval in the first quarter of 2025.This application represents an important milestone in the development of our plots, which will accommodate 28,400 m² of hotel space. Despite a technically complex administrative process, we are proud to report that

atNorth Secures Land in Sweden for Future Mega Site

atNorth has signed an agreement with the Sollefteå Municipality with the intention of building a data center with an initial capacity of 200MWStockholm, Sweden – December 16[th], 2024 –  atNorth , the leading Nordic colocation, high-performance computing, and artificial intelligence service provider, has announced it has secured land in the Sollefteå Municipality, in Hamre Industripark in Långsele, Sweden. The 30 hectare plot is strategically located for its infrastructure, energy capacity and benefits from Sweden’s cool climate, abundance of renewable energy and

Vividye expands its sustainable coloring technology to cosmetic products

The Gothenburg-based deep tech company, originating from Chalmers University of Technology and backed by Chalmers Ventures, is extending the application of its pigment solution from textiles to cosmetics. This will provide safer, non-toxic solutions for coloring cosmetics used in hair color, make-up and lipstick, for instance.GOTHENBURG, Sweden (December 16th, 2024) Vividye , a Swedish deep-tech startup known for its sustainable approach to coloring textiles, is branching out into the cosmetics industry. By adapting its pigment-based technology, the company aims to

BioStock: Chordate Medical’s CEO looks ahead to 2025 — “The exit process is our primary focus”

During 2024, Chordate Medical made progress in establishing Ozilia, a drug-free treatment for chronic migraines and nasal congestion. For example, the company expanded its presence in markets such as Switzerland and Saudi Arabia. BioStock has reached out to CEO Anders Weilandt to learn more about the highlights of 2024 and the goals for the coming year.Read the full article at biostock.se : https://www.biostock.se/en/2024/12/chordate-medicals-ceo-looks-ahead-to-2025-the-exit-process-is-our-primary-focus/ This is a press release from BioStock - Connecting

#24-124 Thinc Collective AB approved for listing at NGM

Nordic Growth Market NGM AB (“NGM“) has, as previously announced, decided to list the shares in Thinc Collective AB at NGM. The first day of trading has been set to December 23, 2024   The shares in Thinc Collective AB have previously been listed at Spotlight Stock Market.   Information regarding the affected instrument:   Listing name: Thinc Exchange symbol: THINC ISIN-code: SE0020358281 CFI-code: ESVUFR FISN-code: THINC/SHInstrument-ID: GF2L Tick size table/liquidity band: 1 Number of issued shares: 17 064 005 First day of trading: 2024-12-23

Flowscape wins business in Sweden

A Swedish company has chosen Flowscape as a supplier for its headquarters. The total order value for the first year is SEK 2.3 million (EUR 200,000) and thereafter SEK 900,000 (EUR 78,000) annually."Flowscape continues to grow with new business in Sweden! We are expanding our fantastic market position with another large installation. This client chose us for our ability to combine a leading user interface with the best analytics portal on the market. With sensors at all work desks and conference rooms, the customer will be able to see detailed occupancy information for the entire office.

Immunovia to host a webcast with the opportunity to learn more about the positive clinical validation of its next-generation pancreatic cancer test

LUND (SWEDEN) – Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, published positive results in the clinical validation of its next-generation test for pancreatic cancer on December 9, 2024. As a follow up, Immunovia will host a webcast on Tuesday, December 17 at 3 pm CET.     Jeff Borcherding, CEO, Norma Alonzo Palma, PhD, VP Clinical and Medical Affairs and Lisa Ford, PhD, Laboratory Director will present additional details about the results and the implications of the study. Dr. Aimee Lucas, Chief of Gastroenterology & Hepatology at Mount Sinai and

Sleep Cycle Partners with Cambridge and UCL for new Alzheimer's Study: Exploring the Link Between Sleep and Early Alzheimer’s Risk

Sleep Cycle, the leading sleep technology company, is thrilled to announce its partnership with researchers from the University of Cambridge and University College London (UCL) on a pioneering Alzheimer’s study. This collaboration combines Sleep Cycle’s comprehensive sleep data with the team’s previous findings to explore potential links between navigation (sense of direction), sleep disruptions, and the early detection of Alzheimer’s disease.The study will explore the potential of using mobile-based sensing data to assist in the early diagnosis of Alzheimer’s disease through analysis of

MilDef concentrates its activities towards the defense sector

MilDef has decided to fully focus its activities on the defense and security domain. The motive behind the strategic focus is the strong market conditions in the defense sector, which in turn is a result of the steep increase in defense spendings. The consequence of the decided direction is that MilDef intends to fully integrate the subsidiary Handheld's portfolio for the defense industry into MilDef's other operations and to cease operations in Handheld's other sales segments.“We choose to focus our efforts instead of splitting our focus, to strengthen MilDef's long-term competitiveness,

Recalculation of warrants of series TO1 following rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. PLEASE SEE "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE.In accordance with the terms and conditions for warrants of series TO1, which were issued in connection with a rights issue of units in February 2024, the number of shares that each warrant entitles the holder to

Jonas Hasselberg resigns as President and CEO of Proact IT Group AB

Jonas Hasselberg has informed the board of his decision to resign from his role as President and CEO of Proact (“Proact”). The board will now begin the process of appointing a new CEO. During the notice period, Jonas Hasselberg will remain in his position to ensure a smooth transition.After nearly seven years as CEO, Jonas Hasselberg is leaving Proact to take on new challenges outside the company. Under Jonas’ leadership, Proact has grown from an annual revenue of approximately 3 billion SEK to nearly 5 billion SEK and now has around 1,200 employees. During the same period, the company’s

Proact IT Group AB (publ) announces weaker system sales and thus a lower result for the fourth quarter compared to the same period last year

Proact IT Group AB announces that sales for the fourth quarter of 2024 are expected to decrease by 10-15 percent and adjusted EBITA by 20-30 percent compared to the same quarter last year. The deviation is explained by a temporary decline in the systems business and a continued challenging market in Germany.After several quarters of good growth in Proact's systems business, lower systems revenue is expected in the fourth quarter compared with the same quarter last year, particularly in Business Unit Nordic & Baltics. In addition the German market remains challenging, which affects Business

NIB finances 20 metro trains for City of Oslo

The Nordic Investment Bank (NIB) has signed a loan with the City of Oslo to finance the acquisition of 20 new metro trains for the Fornebu Metro Line expansion. The Fornebu Metro Line is an extension of the existing metro network, from Majorstuen to Fornebu, and is being constructed in collaboration between the City of Oslo and Akershus County Municipality.The NOK 3.2 billion (EUR 270 million) loan facility will cover Oslo's full share of the metro trains procurement costs, accounting for approximately 11% of the total costs for the Fornebu Metro Line expansion project. The procurement is

Inify Laboratories: Key information regarding potential Subsequent Offering

Reference is made to the stock exchange announcement published today, 16 December 2024, regarding the successful private placement of 30,202,366 new shares (the “Private Placement”) in Inify Laboratories AB (publ) (“Inify” or the “Company”), where it was announced that the Company will, subject to the publication of a national (Norwegian) prospectus, carry out a subsequent offering of 3,464,300 new shares in the Company with gross proceeds of the NOK equivalent of approximately SEK 15 million (the “Subsequent Offering”). The Subsequent Offering will be directed pro-rata towards all

Aker Solutions ASA: Aker Solutions earns Aker BP M&M extension

December 16, 2024 – Aker Solutions has signed a sizeable[1] two-year contract extension for maintenance and modifications work for Aker BP. The contract covers the operated field centers Valhall & Hod, Ula & Tambar, Alvheim and Skarv, offshore Norway.The existing frame agreement where Aker Solutions and Aker BP work under a joint maintenance and modifications alliance model has been extended for a fixed period of two years, from December 2024 to December 2026, and an option to extend for an additional two years will be formalized subject to Aker BP license partners approval. “We see

Dignitana announces legislation signed to require insurance coverage for New York patients using scalp cooling to preserve hair during chemotherapy

Dignitana  announces that New York Governor Kathy Hochul has signed a bill to provide insurance coverage for scalp cooling systems used to preserve hair during chemotherapy treatment for cancer. The act will take effect January 1, 2026. With this legislation (A38-A/S2063-A ), New York becomes the first state in the U.S. to require private health insurers to provide coverage for these devices. The bill,

Aonic welcomes a growth investment of €152m from Metric Capital Partners and Active Ownership

Aonic, a diversified and fast-growing video gaming and technology group, announced it has entered into a definitive agreement to receive a €100m investment from Metric Capital Partners, a leading pan-European investment firm, to further Aonic’s growth ambitions. Besides, Aonic’s major shareholder, Active Ownership, contributes additional capital to Aonic’s equity by converting its €52m shareholder loan. Founded in 2021, Aonic has grown to a globally operating group consisting of 12 different businesses and €151m in LTM revenue as of Q3 2024. This investment marks one of the largest

Esmaeilzadeh Holding publishes net asset value as of 30 November 2024

As of 30 November 2024, the net asset value for Esmaeilzadeh Holding AB (publ) was SEK 6.50 billion (SEK 6.52 billion as of 31 October 2024), corresponding to a net asset value per share of SEK 8,273 (SEK 8,301 as of 31 October 2024).[1]  For further information, please contact: Mikael Ericson, CEO mikael.ericson@ehab.group For press related enquires, please contact: Michaela Abercrombie Simpson, Head of Communications Phone: +46 736 301 403 The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CET on 16

New preclinical data for Cereno Scientific’s novel IP Receptor Agonist CS585 presented at the ASH Annual Meeting and Exposition 2024

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced new preclinical data indicating that drug candidate CS585, a novel prostacyclin (IP) receptor agonist is both highly selective for the IP receptor and provides sustained prevention of thrombus formation. The new data was presented at the ASH Annual Meeting and Exposition 2024, in San Diego 7-10 December 2024.We are pleased to present new preclinical data on our novel IP-receptor agonist, CS585.

Inify Laboratories announces successful placement of fully guaranteed private placement

STOCKHOLM – 16 December 2024 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 9 December 2024 regarding the board of directors' decision to launch a fully guaranteed private placement of 30,000,000 new shares (the “Private Placement Shares”) with gross proceeds of the NOK equivalent of approximately SEK 135 million with a minimum subscription per subscriber of the NOK equivalent of EUR 100,000 (the “Private Placement”), directed pro-rata towards existing shareholders holding more than 400,000 shares in the Company (other than Avanza

Africa Oil Announces Results of Share Buyback Program

VANCOUVER, BC, December 16, 2024 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, or the “Company”) is pleased to announce that the Company repurchased a total of 832,000 Africa Oil common shares during the period of December 9, 2024 to December 13, 2024 under the previously announced share buyback program. During this period, the Company repurchased 309,500 Africa Oil common shares on the TSX and/or alternative Canadian trading systems. The repurchases were carried out by Scotia Capital Inc. on behalf of the Company. During the same period, the Company

Directorate Change

16 December 2024 07:00 GMT Non-Executive Board Appointments AstraZeneca PLC announced today that Rene Haas and Birgit Conix have been appointed as Non-Executive Directors with effect from 1 January 2025 and 1 February 2025 respectively. Birgit will become a member of the Audit Committee on appointment to the Board. Rene is Chief Executive Officer of Arm. Birgit is Chief Financial Officer of Sonova. Further biographical details are set out below. Michel Demaré, Chair of AstraZeneca, said "I am confident Rene and Birgit will be excellent additions to the AstraZeneca Board.  We

There are no items matching the current filter
There are no more items matching the current filter
Back to top